Choice Hotels beats Q3 estimates, raises RevPAR outlook

Choice Hotels reported Q3 adjusted EPS of $2.33 versus $2.28 consensus and revenue of $458 million versus $447.29 million consensus; revenue rose 2.5% year over year. It raised full-year RevPAR and adjusted EBITDA guidance, while lowering net income guidance to $178 million–$185 million from $230 million–$241 million, citing a $24 million contract termination charge and higher marketing expenses. Q3 U.S. RevPAR rose 3.8% year over year, and shares gained 2.55% in pre-market trading; 2026 adjusted diluted EPS guidance of $6.92–$7.07 has a $7.00 midpoint, slightly below the $7.02 consensus.

Analysis

The signal is better demand, but not yet a clear earnings re-acceleration. RevPAR growth appears occupancy-led rather than rate-led, which supports rooms sold but offers less evidence of pricing power; a softer travel backdrop could therefore unwind gains quickly. Net room growth improving is strategically important for a franchisor, but the payoff depends on converting signings into open rooms and recurring royalty revenue.

The guidance mix deserves more scrutiny than the headline beat: adjusted EBITDA guidance moves up modestly at the midpoint, while net income guidance falls sharply, citing a contract-termination charge and higher marketing spend. Treat the charge as nonrecurring only after verifying its cash impact and whether terminations signal broader franchisee or brand friction. Marketing may be an investment in room growth, but if it persists without stronger royalty growth it dilutes the asset-light model’s operating leverage. EPS midpoint is marginally below consensus, limiting the case for a durable estimate-driven rerating.

Near term, the premarket gain may have captured much of the positive surprise. Over 1–3 months, watch net room additions, U.S. RevPAR mix, marketing expense, and the reconciliation between adjusted EBITDA, adjusted EPS, and net income. Over 6–18 months, sustained openings could compound fee revenue; conversely, weak franchisee economics could impair both growth and retention. Marriott International, Hilton, and Wyndham are relevant competitive checks, but this report alone does not establish relative valuation or share gains. The thesis weakens if RevPAR growth slips below guidance, net room growth stalls, or marketing costs keep rising without improved EBITDA conversion.

Key Decisions for Investors

• Avoid chasing CHH on the initial reaction; consider a position only after checking the call and the next operating update for room-opening conversion and franchisee retention.
• For existing CHH exposure, hold conditionally rather than treating the beat as a broad earnings reset. Reassess if RevPAR falls below the revised range or net room growth reverses.
• Track the contract-termination charge’s cash/noncash treatment and the marketing expense run rate. If the charge proves recurring or EBITDA conversion deteriorates, the lower net-income outlook may be more informative than adjusted EBITDA guidance.
• No clean peer pair trade is established by these results alone; compare subsequent RevPAR, room growth, and valuation revisions at Marriott International, Hilton, and Wyndham before expressing relative value.